Stay updated on Roxadustat in End-Stage Renal Disease Clinical Trial
Sign up to get notified when there's something new on the Roxadustat in End-Stage Renal Disease Clinical Trial page.

Latest updates to the Roxadustat in End-Stage Renal Disease Clinical Trial page
- Check7 days agoNo Change Detected
- Check14 days agoChange DetectedAdded: Revision: v3.4.2; Removed: Notice about funding lapse and operating status (v3.4.1).SummaryDifference0.3%

- Check21 days agoChange DetectedAdded a government funding notice about site status (cc.nih.gov and opm.gov) and updated the page revision to v3.4.1, replacing v3.4.0.SummaryDifference0.3%

- Check28 days agoChange DetectedAdded a 'Show glossary' option and a new 'Revision: v3.4.0' tag, with updated QC metadata labeling ('Last Update Submitted that Met QC Criteria') and a new 'No FEAR Act Data' note.SummaryDifference0.2%

- Check35 days agoChange DetectedSponsor attribution changed from FibroGen to Kyntra Bio in the study record. This updates the organization responsible for the study and related contact information.SummaryDifference0.2%

- Check42 days agoChange DetectedRevision tag updated from v3.3.3 to v3.3.4 on the page. This is a minor maintenance update that does not affect study information or user-facing content.SummaryDifference0.0%

- Check64 days agoChange DetectedAdded a Locations section listing study sites by state (Arizona, Arkansas, California, Florida, Hawaii, Kentucky, Michigan, Missouri, New Jersey, New York, Ohio, South Carolina, Texas, Virginia) and updated the page structure accordingly.SummaryDifference1%

Stay in the know with updates to Roxadustat in End-Stage Renal Disease Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Roxadustat in End-Stage Renal Disease Clinical Trial page.